NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . February 9th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Cancer Vaccines - Research reports from University of Cape Town provide new insights into cancer vaccines

Cancer Vaccines - Study results from Y.X. Xu and colleagues in the area of cancer vaccines published

HIV/AIDS - New HIV/AIDS findings from T.W. Geisbert and co-researchers published

HIV/AIDS - New HIV/AIDS study findings reported from B. Silbermann and co-authors

HIV/AIDS - Scientists at Florida State University publish research in HIV/AIDS

HIV/AIDS - Studies from E.C. Speelmon et al add new findings in the area of HIV/AIDS

HIV/AIDS - Studies from University of Paris have provided new data on HIV/AIDS

Immunization - Studies conducted at M. Cruciani et al on immunization recently published



Return to Top of Page

-----------------------
PR Login